184 related articles for article (PubMed ID: 6259441)
1. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P
Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
[TBL] [Abstract][Full Text] [Related]
2. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
[TBL] [Abstract][Full Text] [Related]
3. [Various characteristics of the structure and synthesis of procollagens produced by cultured skin fibroblasts from patients with Danlos-Ehlers syndrome type I].
Sokolov BP; Sher BM; Lomova TIu; Kukharenko VI; Blinnikova OE
Mol Gen Mikrobiol Virusol; 1987 Jan; (1):19-23. PubMed ID: 3561422
[TBL] [Abstract][Full Text] [Related]
4. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
[TBL] [Abstract][Full Text] [Related]
5. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.
Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH
Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
Thakker-Varia S; Anderson DW; Kuivaniemi H; Tromp G; Shin HG; van der Rest M; Glorieux FH; Ala-Kokko L; Stolle CA
Hum Mutat; 1995; 6(2):116-25. PubMed ID: 7581395
[TBL] [Abstract][Full Text] [Related]
7. [Ehlers-Danlos syndrome. Description of 2 clinical cases].
Ottolini A; Berardinelli A; Besana D; Cetta G; Dyne KM; Lanzi G
Minerva Pediatr; 1992 May; 44(5):231-6. PubMed ID: 1620075
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunoassay and electrophoretic separation of collagens secreted by cultured skin fibroblasts of patients with Ehlers-Danlos and Marfan syndromes.
Borisova NV; Safronova EE; Krasnopol'skaya KD; Blinnikova OE; Polyudov SA
Biomed Sci; 1991; 2(5):523-9. PubMed ID: 1840842
[TBL] [Abstract][Full Text] [Related]
9. Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies.
Clark JG; Kuhn C; Uitto J
Am Rev Respir Dis; 1980 Dec; 122(6):971-8. PubMed ID: 7458068
[TBL] [Abstract][Full Text] [Related]
10. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
11. Differential interaction of molecular chaperones with procollagen I and type IV collagen in corneal endothelial cells.
Ko MK; Kay EP
Mol Vis; 2002 Jan; 8():1-9. PubMed ID: 11815750
[TBL] [Abstract][Full Text] [Related]
12. Periodontal Ehlers-Danlos syndrome associated with type III and I collagen deficiencies.
Mataix J; Bañuls J; Muñoz C; Bermejo A; Climent JM
Br J Dermatol; 2008 Apr; 158(4):825-30. PubMed ID: 18284404
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
Stolle CA; Pyeritz RE; Myers JC; Prockop DJ
J Biol Chem; 1985 Feb; 260(3):1937-44. PubMed ID: 2981879
[TBL] [Abstract][Full Text] [Related]
14. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and immunological studies of fibroblasts derived from a patient with Ehlers-Danlos syndrome type IV. Demonstrate reduced type III collagen synthesis.
Aumailley M; Krieg T; Dessau W; Müller PK; Timpl R; Bricaud H
Arch Dermatol Res; 1980; 269(2):169-77. PubMed ID: 7458408
[TBL] [Abstract][Full Text] [Related]
16. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
[TBL] [Abstract][Full Text] [Related]
17. [Synthesis of procollagen proteins in cultured skin fibroblasts of patients with Ehlers-Danlos type I syndrome from a subisolated Azerbaijan population].
Lomova TIu; Sher BM; Shakhova IK; Del'vig AA; Kukharenko VI
Mol Gen Mikrobiol Virusol; 1986 Feb; (2):35-9. PubMed ID: 2946946
[No Abstract] [Full Text] [Related]
18. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV.
Nerlich AG; Stöss H; Lehmann H; Krieg T; Müller PK
Pathol Res Pract; 1994 Aug; 190(7):697-706; discussion 706-7. PubMed ID: 7808968
[TBL] [Abstract][Full Text] [Related]
19. A glycine (415)-to-serine substitution results in impaired secretion and decreased thermal stability of type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
Anderson DW; Thakker-Varia S; Tromp G; Kuivaniemi H; Stolle CA
Hum Mutat; 1997; 9(1):62-3. PubMed ID: 8990011
[No Abstract] [Full Text] [Related]
20. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
